uniQure N.V.
NASDAQ:QUREBiotechnology
-$1.13 today
- Market cap
- $1.42B
- Beta
- 1.00
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$3.33
Volume 1.13M
Average 1.75M
QURE Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
uniQure N.V.NASDAQ: QURE
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $2.96M fell 34.7% year over year, ahead of the -59.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 0.5% from the prior quarter. Over 3 fiscal years it compounded at +20.0% a year.
Context
- Depreciation & amortization amounted to 91.7% of revenue in FY2025, up 45.1 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -34.7% holds above the trailing-twelve-month pace of -59.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 14.76M USD
- Year-over-year change
- +16.8%
- 4-year CAGR
- +19.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.76M | +16.8% |
| FY2024 | 2024-12-31 | 12.64M | +6.2% |
| FY2023 | 2023-12-31 | 11.9M | +39.4% |
| FY2022 | 2022-12-31 | 8.54M | +17.0% |
| FY2021 | 2021-12-31 | 7.3M | — |
Depreciation & Amortization vs competitors
How QURE compares with its peers on the latest reported figures
- QURE's LTM Mar 2026 depreciation & amortization of $5.93M is the 6th largest of the 8 companies compared; the peer median is $10.18M.
- Its year-over-year change of -59.2% is the 7th highest of 8, against a peer median of +0.4%.
- Depreciation & amortization amounts to 32.8% of revenue for QURE, versus a peer median of 9.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $28.32M | +126.8% | +13.8% | 35.5% | |
| LTM Mar 2026 | $15.52M | -3.0% | +6.5% | 17.7% | |
| LTM Mar 2026 | $13.62M | -61.8% | +24.3% | 2.0% | |
| LTM Mar 2026 | $10.18M | +0.4% | +20.7% | — | |
| LTM Mar 2026 | $7.93M | +15.5% | +25.3% | 9.0% | |
| LTM Mar 2026 | $5.93M | -59.2% | +20.0% | 32.8% | |
| LTM Mar 2026 | $3.61M | -20.6% | -13.1% | 9.9% | |
| LTM Mar 2026 | $3.22M | +1.1% | -1.1% | — | |
| Peer median (excluding QURE) | $10.18M | +0.4% | +13.8% | 9.9% | |
Competitors are the stored peer set for QURE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 329.59M | (126.79M) | (308.48M) | (239.56M) | (198.97M) |
| Depreciation & Amortization | 7.3M | 8.54M | 11.9M | 12.64M | 14.76M |
| Deferred Income Tax | 3.21M | (1.47M) | 1.92M | 2.43M | 1.59M |
| Stock-Based Compensation | 25.64M | 34.2M | 35.09M | 22.26M | 17.68M |
| Change in Working Capital | (50.48M) | (43.38M) | 81.12M | (3.94M) | (6.79M) |
| Accounts Receivables | (58.96M) | (49.08M) | (1.32M) | (2.24M) | (8.6M) |
| Inventory | 0 | (6.92M) | (6.74M) | 2.42M | 0 |
| Accounts Payables | (727K) | 9.24M | (4.17M) | 1.52M | (2.67M) |
| Other Working Capital | 9.2M | 3.39M | 93.36M | (5.64M) | 4.47M |
| Other Non-Cash Items | (27.29M) | (16.16M) | 32.51M | 23.44M | (6.23M) |
| Operating Cash Flow | 287.96M | (145.06M) | (145.93M) | (182.73M) | (177.96M) |
| Capital Expenditures | (17.44M) | (17.69M) | (7.15M) | (3.37M) | (439K) |
| Acquisitions (Net) | (49.95M) | (1.9M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | (163.15M) | (366.44M) | (359.84M) | (658.37M) |
| Sales of Investments | 0 | 0 | 167.91M | 534.5M | 337.2M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (67.39M) | (182.73M) | (205.69M) | 162.97M | (321.62M) |
| Debt Repayment | 62.5M | 0 | 370.06M | (53.05M) | 0 |
| Common Stock Issued | 33.7M | 1.45M | 308K | 2.12M | 391.9M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.33M) | 0 | (7.65M) | (8.56M) | 23.5M |
| Financing Cash Flow | 94.86M | 1.45M | 362.72M | (59.49M) | 415.4M |
| Effect of Forex Changes | (3.76M) | (1.83M) | 2.27M | (4.97M) | 5.49M |
| Net Change in Cash | 311.67M | (328.18M) | 13.37M | (84.22M) | (78.69M) |
| Free Cash Flow | 270.52M | (162.75M) | (153.08M) | (186.1M) | (177.96M) |
uniQure N.V.
NASDAQ:QURE
Intrinsic Alpha fair value
Locked
Current Price
$20.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.